Biao Cheng | Molecular Biology | Best Researcher Award

Prof. Dr. Biao Cheng | Molecular Biology | Best Researcher Award 

General Hospital of Southern Theater Command, Guangzhou, China

👨‍🎓Profiles

📚 Early Academic Pursuits

Biao Cheng embarked on his academic journey with a strong foundation in medical sciences, focusing on dermatology, plastic surgery, and regenerative medicine. His early research revolved around wound healing mechanisms and innovative therapeutic approaches. With a keen interest in advancing medical treatments, he dedicated himself to understanding platelet-derived products and their applications in skin tissue repair. His academic pursuits laid the groundwork for significant contributions to regenerative medicine, particularly in developing standardized methods for platelet concentrate preparation.

🏥 Professional Endeavors

As a Professor and Chief Director at the Dermatology Hospital, Southern Medical University, and the Department of Burn and Plastic Surgery at the General Hospital of Southern Theater Command, Cheng has been at the forefront of advancements in burn treatment, trauma care, and tissue regeneration. His extensive research in platelet concentrates and regenerative medicine has had a profound impact on clinical practices, improving patient outcomes. He has led various pioneering projects aimed at optimizing platelet-derived therapies and their applications in reconstructive and aesthetic medicine, bridging the gap between research and real-world medical treatments.

🔬 Contributions and Research Focus

Cheng’s research primarily centers on wound healing, platelet-derived therapies, and burn treatment, with a particular emphasis on regenerative medicine. He has played a crucial role in developing standardized platelet concentrate preparation techniques, which have become essential in clinical applications. His work has led to the creation of innovative biomaterials, such as antibacterial composite scaffolds and rolling injection devices, designed to enhance wound healing, even under extreme conditions. His research has not only contributed to scientific advancements but has also been instrumental in improving medical interventions for trauma and burn patients.

🌍 Impact and Influence

With a citation index of 29, Cheng’s contributions have gained widespread recognition in the fields of dermatology, plastic surgery, and regenerative medicine. His research findings have been published in esteemed journals, including Wound Repair and Regeneration, British Journal of Dermatology, and Stem Cells and Development, shaping the direction of modern wound healing treatments. His extensive body of work has influenced both academic research and clinical applications, making him a prominent figure in the field of regenerative medicine.

📖 Academic Contributions

Cheng has made significant contributions to medical literature through his authorship of several authoritative books. His works, including 《Platelet-Rich Plasma in Tissue Repair and Regeneration》, 《Growth Factors and Skin Tissue Repair》, and 《Guidelines for the Regenerative and Rehabilitation Applications of Concentrated Platelets》, serve as valuable references for researchers and medical practitioners alike. These publications provide critical insights into the applications of platelet-derived therapies and growth factors in tissue repair and regeneration, further advancing knowledge in the field.

🛠️ Technical Skills

Cheng possesses extensive expertise in a range of advanced medical technologies. His proficiency includes Platelet-Rich Plasma (PRP) and Growth Factor Therapies, Stem Cell-Based Regenerative Medicine, Intelligent Negative Pressure Wound Therapy, and the Development of Advanced Biomaterials for Wound Healing. His technical skills have been instrumental in developing novel therapeutic solutions for skin tissue repair, trauma treatment, and aesthetic medicine. His contributions to medical technology continue to push the boundaries of innovation in regenerative medicine.

🎓 Teaching and Mentorship

As a dedicated educator, Cheng has played a pivotal role in mentoring students and young researchers in tissue engineering, plastic surgery, and regenerative medicine. His guidance has helped shape the careers of numerous medical professionals, ensuring the continuity of innovative research in the field. Beyond the classroom, he actively participates in national and international medical conferences, sharing his knowledge and insights with the broader medical community. His commitment to teaching extends to training programs, where he equips medical practitioners with the latest advancements in regenerative treatments.

🏆 Legacy and Future Contributions

Cheng’s ongoing research and contributions continue to shape the future of regenerative medicine. His commitment to developing next-generation wound healing solutions and standardizing concentrated platelet products for clinical use remains a driving force in the field. His vision for the future includes further refining regenerative medicine techniques to improve their efficacy in aesthetic and reconstructive surgery. As an active member of leading medical committees and a reviewer for top dermatologic journals, he plays a vital role in shaping policies and guiding research directions in tissue repair and regenerative medicine. His legacy will be defined by his groundbreaking contributions, ensuring that innovative medical treatments reach a broader spectrum of clinical applications.

📖Notable Publications

Innate lymphoid cell-based immunomodulatory hydrogel microspheres containing Cutibacterium acnes extracellular vesicles for the treatment of psoriasis

Authors: Xu Yujie, Gan Yuyang, Qi Fangfang, Hu Zhiqi, Wang Gaofeng

Journal: Acta Biomaterialia

Year: 2024

Luminescence-activated Pt(IV) prodrug for in situ triggerable cancer therapy

Authors: An Huijie, Yang Chen, Jiang Zhihui, Liu Hongjiang, Yu Zhiqiang

Journal: Chinese Chemical Letters

Year: 2024

Antibacterial Antimicrobial Peptide Grafted HA/SF/Alg Wound Dressing Containing AIEgens for Infected Wound Treating

Authors: Lin Yize, Tan Yan, Deng Rong, Cheng Biao, Chen Yi

Journal: ACS Omega

Year: 2024

Transconjunctival Fat Repositioning Blepharoplasty: Is Excess Fat Herniation a Prerequisite?

Authors: Chen Jianwu, Wu Yanhong, Wang Yuzhi, Huang Wenhua, Cheng Biao

Journal: Plastic and Reconstructive Surgery

Year: 2024

Clinical efficacy of blood derivatives on wound healing: A systematic review and network meta-analysis

Authors: Wu Yanhong, Peng Guang, Wang Yuzhi, Tang Jianbing, Cheng Biao

Journal: International Wound Journal

Year: 2024

The Role of Stem Cells on Wound Healing After Revascularization—Healing Following Revascularization—Unlocking Skin Potential

Authors: Cheng Biao, Fu Xiaobing

Journal: The International Journal of Lower Extremity Wounds

Year: 2024

 

 

Duk-Hwa Kwon | Molecular Biology | Best Researcher Award -1610

Dr. Duk-Hwa Kwon | Molecular Biology | Best Researcher Award

Chonnam National University Medical School, South Korea

👨‍🎓Profiles

🎓 Early Academic Pursuits

He began his academic journey in biotechnology, earning his B.S. degree from Chonnam National University, Gwangju, Korea, between 2002 and 2007. Building on his passion for the life sciences, he pursued an M.S. in Biotechnology at the same institution from 2007 to 2009. His early academic endeavors laid a strong foundation in the principles of biological sciences, molecular mechanisms, and biotechnological applications.

🏛️ Professional Endeavors

Following his academic training, He advanced to a Ph.D. in Biomedical Sciences (2011–2014) at Chonnam National University's Medical School. Post-graduation, he transitioned to a postdoctoral fellowship in the Department of Pharmacology at the same university, where he has been serving since 2014. In this role, Dr. Kwon has collaborated on cutting-edge pharmacological research, contributing significantly to the university's academic and scientific reputation.

🔬 Contributions and Research Focus

His research has primarily focused on the intersection of biotechnology and pharmacology. His work has explored molecular mechanisms underlying diseases, drug discovery, and the development of innovative therapeutic strategies. He has contributed to understanding biomedical pathways, significantly advancing pharmacological knowledge and biomedical applications.

🌍 Impact and Influence

His academic and professional contributions have had a profound impact on the fields of biotechnology and pharmacology. By combining foundational biotechnology knowledge with clinical applications, he has addressed critical health challenges, providing innovative solutions to modern medical problems. His work continues to influence the direction of pharmacological research globally.

📚 Academic Citations

As a researcher, He has accumulated a noteworthy number of citations, reflecting the academic community's recognition of his impactful research. His publications have appeared in prestigious journals, marking him as a key contributor to his field.

🛠️ Technical Skills

He possesses advanced technical skills in biotechnology and pharmacology, including molecular biology techniques, drug screening methods, and cell culture systems. His expertise also spans advanced pharmacological modeling and data analysis.

🧑‍🏫 Teaching Experience

In addition to his research roles, He has contributed to academic teaching. His mentorship of students and involvement in laboratory training have helped shape the next generation of researchers and scientists in biotechnology and pharmacology.

🌟 Legacy and Future Contributions

His dedication to biomedical sciences and pharmacology positions him as a leading figure in his field. His legacy lies in his ability to bridge the gap between biotechnology and clinical applications, ensuring that his contributions continue to benefit academia and industry. Looking forward, Dr. Kwon is poised to expand his research into innovative therapies, furthering advancements in healthcare and biomedical science.

📖Notable Publications

MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification

Authors: DH Kwon, GH Eom, JH Ko, S Shin, H Joung, N Choe, YS Nam, HK Min, ...
Journal: Nature Communications
Year: 2016

The microRNA miR‐124 inhibits vascular smooth muscle cell proliferation by targeting S100 calcium‐binding protein A4 (S100A4)

Authors: N Choe, DH Kwon, S Shin, YS Kim, YK Kim, J Kim, Y Ahn, GH Eom, ...
Journal: FEBS Letters
Year: 2017

Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4

Authors: DH Kwon, GH Eom, HJ Kee, YS Nam, YK Cho, DK Kim, JY Koo, HS Kim, ...
Journal: Journal of Molecular and Cellular Cardiology
Year: 2013

Characterization of circular RNAs in vascular smooth muscle cells with vascular calcification

Authors: J Ryu, DH Kwon, N Choe, S Shin, G Jeong, YH Lim, J Kim, WJ Park, ...
Journal: Molecular Therapy-Nucleic Acids
Year: 2020

PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart

Authors: S Yoon, T Kook, HK Min, DH Kwon, YK Cho, M Kim, S Shin, H Joung, ...
Journal: Experimental & Molecular Medicine
Year: 2018

Long noncoding RNAs in vascular smooth muscle cells regulate vascular calcification
Authors: G Jeong, DH Kwon, S Shin, N Choe, J Ryu, YH Lim, J Kim, WJ Park, ...
Journal: Scientific Reports
Year: 2019